|
 |
 |
|
|
|
|||||
| Overview What is the OVATURE Trial? Treatments Eligibility Criteria Check Your Eligibility |
 OVATURE (OVArian TUmor REsponse) is a Phase III pivotal clinical trial sponsored by Marshall Edwards to compare the investigational drug phenoxodiol in combination with carboplatin to phenoxodiol placebo in combination with carboplatin. The aim of the study is to find out if phenoxodiol given orally in combination with carboplatin is effective in treating women with recurrent ovarian cancer. » Study summary » What are the eligibility criteria? |
140 Wicks Road North Ryde NSW 2113 Australia T: +61 2 8877 6196  |
      
|
| . |
home
: about us.
: about phenoxodiol
: the technology
: newsroom
: Marshall Edwards Inc. 2001 ©
|